Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Celularity Inc | CELU | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.38 | 07:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.38 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.59 - 8.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 3.38 | USD |
Celularity Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 222.19M | 21.78M | - | 17.98M | 14.19M | 0.65 | 15.66 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Celularity News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CELU Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.29 | 3.49 | 2.99 | 3.20 | 29,549 | 0.09 | 2.74% |
| 1 Month | 5.02 | 5.69 | 2.99 | 4.39 | 40,635 | -1.64 | -32.67% |
| 3 Months | 4.10 | 7.97 | 2.99 | 4.72 | 420,356 | -0.72 | -17.56% |
| 6 Months | 2.15 | 7.97 | 1.59 | 3.05 | 1,348,252 | 1.23 | 57.21% |
| 1 Year | 6.072 | 8.90 | 1.59 | 3.54 | 1,017,871 | -2.69 | -44.33% |
| 3 Years | 107.191 | 134.00 | 1.59 | 17.78 | 632,061 | -103.81 | -96.85% |
| 5 Years | 107.191 | 134.00 | 1.59 | 17.78 | 632,061 | -103.81 | -96.85% |
Celularity Description
| Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. |
